Jonathan Kennedy
CIK 1451629 · President and CEO · last filed 2021-05-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.88M
Companies
3
Total Filings
56
Lifetime Open-Market Net
-$6.89M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NATUS MEDICAL INC (NTUS) Delisted | President and CEO | 191,810 | $32.96 | $6.32M | -$505.6K | 8 | 2021-05-04 |
| IRMD | Director | 19,759 | $95.08 | $1.88M | $0 | 9 | 2019-06-19 |
| NATUS MEDICAL INC (BABY) Delisted | President and CEO | 139,517 | — | — | -$6.38M | 16 | 2019-01-24 |
Recent Filings · Page 4 of 6
56 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-12-11 | NATUS MEDICAL INC (BABY) Delisted | Mixed | — | -$1.03M | EDGAR |
| 2014-01-03 | NATUS MEDICAL INC (BABY) Delisted | Grant (A) | +20,000 | $20 | EDGAR |
| 2013-04-09 | NATUS MEDICAL INC (BABY) Delisted | Grant (A) | +60,000 | $60 | EDGAR |
| 2012-10-03 | — | Sell (S) | −746 | -$6.4K | |
| 2012-07-02 | — | Mixed | +474 | -$2.9K | |
| 2012-04-04 | — | Exer (M) | — | $0 | |
| 2012-04-03 | — | Mixed | +3,640 | -$23.6K | |
| 2012-01-05 | — | Mixed | +5,816 | -$42.0K | |
| 2011-10-05 | — | Exer (M) | — | $0 | |
| 2011-07-05 | — | Mixed | +474 | -$3.6K |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.